دورية أكاديمية

1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial

التفاصيل البيبلوغرافية
العنوان: 1806P Efficacy of niraparib and abiraterone acetate plus prednisone (NIRA+AAP) in homologous recombination repair gene-altered (HRR+) metastatic castration-resistant prostate cancer (mCRPC) by tissue and/or plasma assays in the MAGNITUDE trial
المؤلفون: Attard, G., Sandhu, S.K., Rathkopf, D., Castro, E., Saad, M., Smith, M.R., Small, E.J.J., Olmos, D., Gomes, A.J.P.D.S., Roubaud, G., Zurawski, B., Efstathiou, E., Wu, D., Diorio, B., Urtishak, K., Singh, U., Xu, Y., Lopez-Gitlitz, A., del Corral, A., Chi, K.N.N.
المصدر: Annals of Oncology ; volume 34, page S976-S977 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.annonc.2023.09.2754
الإتاحة: https://doi.org/10.1016/j.annonc.2023.09.2754Test
https://api.elsevier.com/content/article/PII:S0923753423035913?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753423035913?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.1B0C4CBD
قاعدة البيانات: BASE